Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

World Health Organization.

In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...

Tuberculosis/tratamiento farmacológico, Infecciones por VIH/complicaciones, Isoniazida/uso terapéutico, Valor Predictivo de las Pruebas, Países en Desarrollo

Texto completo

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

World Health Organization.

This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recomme...

Profilaxis Pre-Exposición, Infecciones por VIH/prevención & control, Infecciones por VIH/tratamiento farmacológico, Antirretrovirales/uso terapéutico, Tenofovir/uso terapéutico, Tiempo de Tratamiento

Texto completo

Consolidated guidelines on HIV testing services

World Health Organization.

The Consolidated guidelines on HIV testing services bring together existing guidance relevant to the provision of HIV testing services (HTS) and addresses issues and elements for effective delivery of HTS that are common in a variety of settings, contexts and diverse populations. In addition, this docume...

Serodiagnóstico del SIDA, Infecciones por VIH, Consejo Dirigido, Promoción de la Salud, Pruebas Diagnósticas de Rutina

Texto completo